These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38393903)

  • 1. The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer's Disease: A Longitudinal Study.
    Rapos Pereira F; George N; Dalla Barba G; Dubois B; La Corte V;
    J Alzheimers Dis; 2024; 98(2):465-479. PubMed ID: 38393903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The memory binding test can anticipate Alzheimer's disease diagnosis at an early preclinical stage: a longitudinal study in the INSIGHTpreAD cohort.
    Raposo Pereira F; George N; Dalla Barba G; Dubois B; La Corte V
    Front Aging Neurosci; 2024; 16():1414419. PubMed ID: 39175810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
    Teng E; Manser PT; Shah M; Pickthorn K; Hu N; Djakovic S; Swendsen H; Blendstrup M; Faccin G; Ostrowitzki S; Sink KM
    J Prev Alzheimers Dis; 2023; 10(1):41-49. PubMed ID: 36641609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease.
    Papp KV; Amariglio RE; Mormino EC; Hedden T; Dekhytar M; Johnson KA; Sperling RA; Rentz DM
    Neuropsychologia; 2015 Jul; 73():169-75. PubMed ID: 26002757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct validity of the Free and Cued Selective Reminding Test in older adults with memory complaints.
    Clerici F; Ghiretti R; Di Pucchio A; Pomati S; Cucumo V; Marcone A; Vanacore N; Mariani C; Cappa SF
    J Neuropsychol; 2017 Jun; 11(2):238-251. PubMed ID: 26560406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which Episodic Memory Performance is Associated with Alzheimer's Disease Biomarkers in Elderly Cognitive Complainers? Evidence from a Longitudinal Observational Study with Four Episodic Memory Tests (Insight-PreAD).
    Gagliardi G; Epelbaum S; Houot M; Bakardjian H; Boukadida L; Revillon M; Dubois B; Dalla Barba G; La Corte V;
    J Alzheimers Dis; 2019; 70(3):811-824. PubMed ID: 31282413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.
    Matias-Guiu JA; Cabrera-Martín MN; Curiel RE; Valles-Salgado M; Rognoni T; Moreno-Ramos T; Carreras JL; Loewenstein DA; Matías-Guiu J
    J Alzheimers Dis; 2018; 61(1):103-111. PubMed ID: 29125488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.
    Gramunt N; Sánchez-Benavides G; Buschke H; Lipton RB; Masramon X; Gispert JD; Peña-Casanova J; Fauria K; Molinuevo JL
    J Alzheimers Dis; 2016; 50(4):999-1010. PubMed ID: 26836167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroanatomical Comparison of the "Word" and "Picture" Versions of the Free and Cued Selective Reminding Test in Alzheimer's Disease.
    Slachevsky A; Barraza P; Hornberger M; Muñoz-Neira C; Flanagan E; Henríquez F; Bravo E; Farías M; Delgado C
    J Alzheimers Dis; 2018; 61(2):589-600. PubMed ID: 29226861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cued memory decline in biomarker-defined preclinical Alzheimer disease.
    Papp KV; Rentz DM; Mormino EC; Schultz AP; Amariglio RE; Quiroz Y; Johnson KA; Sperling RA
    Neurology; 2017 Apr; 88(15):1431-1438. PubMed ID: 28283594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Metabolism Correlates of the Free and Cued Selective Reminding Test in Mild Cognitive Impairment.
    Caffarra P; Ghetti C; Ruffini L; Spallazzi M; Spotti A; Barocco F; Guzzo C; Marchi M; Gardini S
    J Alzheimers Dis; 2016; 51(1):27-31. PubMed ID: 26836012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

  • 14. The free and cued selective reminding test: Validation for mild cognitive impairment and Alzheimer's disease.
    Lemos R; Simões MR; Santiago B; Santana I
    J Neuropsychol; 2015 Sep; 9(2):242-57. PubMed ID: 24894485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer's Disease.
    García-Martínez M; Pozueta-Cantudo A; Lage C; Martínez-Dubarbie F; López-García S; Fernández-Matarrubia M; Corrales-Pardo A; Bravo M; Cavada NC; Anuarbe P; Infante J; López-Higuera JM; Rodríguez-Cobo L; Rodríguez-Rodríguez E; Butler CR; Sánchez-Juan P
    J Alzheimers Dis; 2024; 100(3):1039-1053. PubMed ID: 38943389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Out-Test: A New Paradigm for Sorting the Wheat from the Chaff in Prodromal Alzheimer's Disease.
    Torrealba E; Garcia-Morales P; Cejudo JC; Diaz M; Rodriguez-Esparragon F; Fabre O; Mesa-Herrera F; Marin R; Sanchez-Garcia F; Rodriguez-Perez A; Gramunt N
    J Alzheimers Dis; 2019; 67(1):265-277. PubMed ID: 30530971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease.
    Benejam B; Aranha MR; Videla L; Padilla C; Valldeneu S; Fernández S; Altuna M; Carmona-Iragui M; Barroeta I; Iulita MF; Montal V; Pegueroles J; Bejanin A; Giménez S; González-Ortiz S; Videla S; Bartrés-Faz D; Alcolea D; Blesa R; Lleó A; Fortea J
    Alzheimers Res Ther; 2022 Sep; 14(1):123. PubMed ID: 36057615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.
    Langbaum JB; Ellison NN; Caputo A; Thomas RG; Langlois C; Riviere ME; Graf A; Lopez Lopez C; Reiman EM; Tariot PN; Hendrix SB
    Alzheimers Res Ther; 2020 May; 12(1):66. PubMed ID: 32460855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.